Search

Search Constraints

You searched for: Author/Creator Smith, Mark E. B.

Search Results

2. A platform for efficient, thiol-stable conjugation to albumin's native single accessible cysteine1. Issue 29 (7th August 2015)

3. Correction: Optimisation of the dibromomaleimide (DBM) platform for native antibody conjugation by accelerated post-conjugation hydrolysis. Issue 13 (24th March 2021)

4. Functional native disulfide bridging enables delivery of a potent, stable and targeted antibody–drug conjugate (ADC)1. Issue 53 (7th July 2015)

5. Optimisation of the dibromomaleimide (DBM) platform for native antibody conjugation by accelerated post-conjugation hydrolysis. Issue 14 (14th March 2017)

6. Pyridazinediones deliver potent, stable, targeted and efficacious antibody–drug conjugates (ADCs) with a controlled loading of 4 drugs per antibody. Issue 15 (30th January 2017)

7. Use of a next generation maleimide in combination with THIOMAB™ antibody technology delivers a highly stable, potent and near homogeneous THIOMAB™ antibody-drug conjugate (TDC). Issue 40 (10th May 2017)